NEBIVOLOL
Nebivolol is a newer generation β-blocker with high
affinity for β1-receptors.
The drug is unique in its ability to cause direct vasodilation via its
stimulatory effect on endothelial nitric oxide synthase. It is pres-ently
available only in oral formulation; the recom-mended dose is 5–40 mg daily.
Related Topics
Privacy Policy, Terms and Conditions, DMCA Policy and Compliant
Copyright © 2018-2024 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.